NT5E and Cognitive impairment: In the present study, A2AR antagonist SCH58261 exerted anti-inflammatory and anti-glutamate excitatory neurotoxicity by blocking CD73/adenosine/A2AR pathway, ultimately improving the cognitive impairment caused by CP.